Please Wait
Applying Filters...
menu
    • menu
    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Lucitanib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clovis Oncology Announces First Patient Enrolled in the Ph2 Portion the LIO-1
    Clovis Oncology Announces First Patient Enrolled in the Ph2 Portion the LIO-1

    04 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200805005359/en

    BUSINESSWIRE
    04 Aug 2020
    Share Share
    New Preclinical Data on ALKS 4230 in Comb Lucitanib Presented at 2020 (AACR)
    New Preclinical Data on ALKS 4230 in Comb Lucitanib Presented at 2020 (AACR)

    22 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/new-preclinical-data-on-alks-4230-in-combination-with-lucitanib-to-be-presented-at-2020-american-association-for-cancer-research-aacr-virtual-annual-meeting-ii-301080515.html

    PRNEWSWIRE
    22 Jun 2020
    Share Share
    Clovis Oncology to Highlight Rubraca®& Lucitanib Non-Clinical Data at the AACR
    Clovis Oncology to Highlight Rubraca®& Lucitanib Non-Clinical Data at the AACR

    17 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200617005130/en

    BUSINESSWIRE
    17 Jun 2020
    Share Share
    Meet the protein responsible for nearly $100B in cancer drug deals
    Meet the protein responsible for nearly $100B in cancer drug deals

    17 Aug 2019

    // Jacob Bell BIOPHARMADIVE

    https://www.biopharmadive.com/news/meet-the-protein-responsible-for-nearly-100b-in-cancer-drug-deals/561097/

    Jacob Bell BIOPHARMADIVE
    17 Aug 2019
    Share Share
    Clovis Oncology Announces Interim Results from Rubraca® (rucaparib)
    Clovis Oncology Announces Interim Results from Rubraca® (rucaparib)

    02 Apr 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190402005328/en/Clovis-Oncology-Announces-Interim-Results-Rubraca%C2%AE-rucaparib/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    02 Apr 2019
    Share Share
    Clovis loses Servier pact, agrees to settle SEC case
    Clovis loses Servier pact, agrees to settle SEC case

    02 Aug 2018

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/clovis-loses-servier-pact-agrees-to-settle-sec-case

    Nick Paul Taylor FIERCE BIOTECH
    02 Aug 2018
    Share Share